Issue 6, 2019

Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application

Abstract

An integrated experimental/computational strategy to study the binding modes of metal species to proteins is presented. With this multistep method based on the combined application of spectrometric (ESI-MS), spectroscopic (EPR) and computational (docking and QM) techniques, the interaction of VIVO2+ and four potential drugs VIVOL2 (L = 1,2-dimethyl-3-hydroxy-4(1H)-pyridinonate or dhp, L-mimosinate or mim, maltolate or ma, acetylacetonate or acac) with myoglobin (Mb) was characterized. ESI-MS allows the determination of the number of moieties (VOL+ or VOL2) bound to the protein, EPR helps distinguish the type of coordinating donors, and docking and full QM models allow the prediction of the specific residues involved in the V coordination as well as the 3D structure of the adducts. The results indicate that VIVO2+ ions bind to three different sites with the involvement of three residues of the polypeptide chain (His, Asp and Glu). In the systems with dhp and mim, mixed species {VOL2}n(Mb) with n = 2 (dhp) and 3–4 (mim) were formed with the equatorial coordination of one exposed His residue. With ma and acac, adducts with the general formula {VOL}n(Mb) with n = 2 were identified with the simultaneous binding of two residues (Glu, Asp or His) to two adjacent positions of the VOL+ moiety. This approach is generalizable and could be applied to other metal ions and proteins using – depending on the metal features – different spectroscopic techniques.

Graphical abstract: Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application

Supplementary files

Article information

Article type
Research Article
Submitted
20 Feb 2019
Accepted
16 Apr 2019
First published
15 May 2019

Inorg. Chem. Front., 2019,6, 1561-1578

Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application

G. Sciortino, D. Sanna, V. Ugone, J. Maréchal and E. Garribba, Inorg. Chem. Front., 2019, 6, 1561 DOI: 10.1039/C9QI00179D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements